{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:50:28Z","timestamp":1786981828410,"version":"build-2736575974"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T00:00:00Z","timestamp":1601596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T00:00:00Z","timestamp":1601596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K08AG048354"],"award-info":[{"award-number":["K08AG048354"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG067333"],"award-info":[{"award-number":["AG067333"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ketone bodies are endogenous metabolites that are linked to multiple mechanisms of aging and resilience. They are produced by the body when glucose availability is low, including during fasting and dietary carbohydrate restriction, but also can be consumed as exogenous ketone compounds. Along with supplying energy to peripheral tissues such as brain, heart, and skeletal muscle, they increasingly are understood to have drug-like protein binding activities that regulate inflammation, epigenetics, and other cellular processes. While these energy and signaling mechanisms of ketone bodies are currently being studied in a variety of aging-related diseases such as Alzheimer\u2019s disease and type 2 diabetes mellitus, they may also be relevant to military service members undergoing stressors that mimic or accelerate aging pathways, particularly traumatic brain injury and muscle rehabilitation and recovery. Here we summarize the biology of ketone bodies relevant to resilience and rehabilitation, strategies for translational use of ketone bodies, and current clinical investigations in this area.<\/jats:p>","DOI":"10.1007\/s11357-020-00277-y","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T09:04:20Z","timestamp":1601629460000},"page":"1071-1081","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["From bedside to battlefield: intersection of ketone body mechanisms in geroscience with military resilience"],"prefix":"10.1007","volume":"43","author":[{"given":"Brianna J.","family":"Stubbs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Koutnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff S.","family":"Volek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8455-0100","authenticated-orcid":false,"given":"John C.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,2]]},"reference":[{"issue":"5","key":"277_CR1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/iub.1627","volume":"69","author":"RL Veech","year":"2017","unstructured":"Veech RL, Bradshaw PC, Clarke K, Curtis W, Pawlosky R, King MT. Ketone bodies mimic the life span extending properties of caloric restriction. IUBMB Life. 2017;69(5):305\u201314.","journal-title":"IUBMB Life"},{"key":"277_CR2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-nutr-071816-064916","volume":"37","author":"JC Newman","year":"2017","unstructured":"Newman JC, Verdin E. beta-Hydroxybutyrate: a signaling metabolite. Annu Rev Nutr. 2017;37:51\u201376.","journal-title":"Annu Rev Nutr"},{"issue":"4","key":"277_CR3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s12276-020-0415-z","volume":"52","author":"YM Han","year":"2020","unstructured":"Han YM, Ramprasath T, Zou MH. \u03b2-Hydroxybutyrate and its metabolic effects on age-associated pathology. Exp Mol Med. 2020;52(4):548\u201355.","journal-title":"Exp Mol Med"},{"issue":"2","key":"277_CR4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nrn.2017.156","volume":"19","author":"MP Mattson","year":"2018","unstructured":"Mattson MP, Moehl K, Ghena N, Schmaedick M, Cheng A. Intermittent metabolic switching, neuroplasticity and brain health. Nat Rev Neurosci. 2018;19(2):63\u201380.","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"277_CR5","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/mp.2014.111","volume":"19","author":"MW Miller","year":"2014","unstructured":"Miller MW, Sadeh N. Traumatic stress, oxidative stress and post-traumatic stress disorder: neurodegeneration and the accelerated-aging hypothesis. Mol Psychiatry. 2014;19(11):1156\u201362.","journal-title":"Mol Psychiatry"},{"issue":"5","key":"277_CR6","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jagp.2019.01.001","volume":"27","author":"AJF Tamman","year":"2019","unstructured":"Tamman AJF, Montalvo-Ortiz JL, Southwick SM, Krystal JH, Levy BR, Pietrzak RH. Accelerated DNA methylation aging in U.S. military veterans: results from the National Health and Resilience in Veterans Study. Am J Geriatr Psychiatry. 2019;27(5):528\u201332.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"9","key":"277_CR7","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2174\/15672050113109990142","volume":"10","author":"DP Veitch","year":"2013","unstructured":"Veitch DP, Friedl KE, Weiner MW. Military risk factors for cognitive decline, dementia and Alzheimer's disease. Curr Alzheimer Res. 2013;10(9):907\u201330.","journal-title":"Curr Alzheimer Res"},{"issue":"3 Suppl","key":"277_CR8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0749-3797(00)00107-0","volume":"18","author":"TJ Songer","year":"2000","unstructured":"Songer TJ, LaPorte RE. Disabilities due to injury in the military. Am J Prev Med. 2000;18(3 Suppl):33\u201340.","journal-title":"Am J Prev Med"},{"issue":"1","key":"277_CR9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00043764-199701000-00013","volume":"39","author":"M Feuerstein","year":"1997","unstructured":"Feuerstein M, Berkowitz SM, Peck CA Jr. Musculoskeletal-related disability in US Army personnel: prevalence, gender, and military occupational specialties. J Occup Environ Med. 1997;39(1):68\u201378.","journal-title":"J Occup Environ Med"},{"issue":"5","key":"277_CR10","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.neubiorev.2012.02.013","volume":"36","author":"TM Sivanandam","year":"2012","unstructured":"Sivanandam TM, Thakur MK. Traumatic brain injury: a risk factor for Alzheimer's disease. Neurosci Biobehav Rev. 2012;36(5):1376\u201381.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"277_CR11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1152\/physrev.1980.60.1.143","volume":"60","author":"AM Robinson","year":"1980","unstructured":"Robinson AM, Williamson DH. Physiological roles of ketone-bodies as substrates and signals in mammalian-tissues. Physiol Rev. 1980;60(1):143\u201387.","journal-title":"Physiol Rev"},{"issue":"6","key":"277_CR12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/(SICI)1520-7560(199911\/12)15:6<412::AID-DMRR72>3.0.CO;2-8","volume":"15","author":"L Laffel","year":"1999","unstructured":"Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev. 1999;15(6):412\u201326.","journal-title":"Diabetes Metab Res Rev"},{"key":"277_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.nutr.26.061505.111258","volume":"26","author":"GF Cahill Jr","year":"2006","unstructured":"Cahill GF Jr. Fuel metabolism in starvation. Annu Rev Nutr. 2006;26:1\u201322.","journal-title":"Annu Rev Nutr"},{"issue":"3","key":"277_CR14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1079\/PNS19900042","volume":"49","author":"AJ Rich","year":"1990","unstructured":"Rich AJ. Ketone bodies as substrates. Proc Nutr Soc. 1990;49(3):361\u201373.","journal-title":"Proc Nutr Soc"},{"key":"277_CR15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0065-2571(66)90027-6","volume":"4","author":"HA Krebs","year":"1966","unstructured":"Krebs HA. The regulation of the release of ketone bodies by the liver. Adv Enzym Regul. 1966;4:339\u201354.","journal-title":"Adv Enzym Regul"},{"key":"277_CR16","doi-asserted-by":"crossref","unstructured":"Wheless, J.W., Chapter 2\u2014History and origin of the ketogenic diet. Epilepsy and the ketogenic diet. 2004: Humana Press Inc.","DOI":"10.1007\/978-1-59259-808-3_2"},{"issue":"3","key":"277_CR17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/eci.12591","volume":"46","author":"AF Branco","year":"2016","unstructured":"Branco AF, Ferreira A, Sim\u00f5es RF, Magalh\u00e3es-Novais S, Zehowski C, Cope E, et al. Ketogenic diets: from cancer to mitochondrial diseases and beyond. Eur J Clin Investig. 2016;46(3):285\u201398.","journal-title":"Eur J Clin Investig"},{"key":"277_CR18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.molmet.2019.06.026","volume":"33","author":"DD Weber","year":"2020","unstructured":"Weber DD, Aminzadeh-Gohari S, Tulipan J, Catalano L, Feichtinger RG, Kofler B. Ketogenic diet in the treatment of cancer\u2014where do we stand? Mol Metab. 2020;33:102\u201321.","journal-title":"Mol Metab"},{"issue":"Suppl 1","key":"277_CR19","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1007\/s40279-015-0393-9","volume":"45","author":"LM Burke","year":"2015","unstructured":"Burke LM. Re-examining high-fat diets for sports performance: did we call the \u201cNail in the Coffin\u201d too soon? Sports Med. 2015;45(Suppl 1):S33\u201349.","journal-title":"Sports Med"},{"key":"277_CR20","doi-asserted-by":"crossref","unstructured":"Burke L and Kiens B., \u201cfat adaptations\u201d for athletic performance: the nail in the coffin? J Appl Physiol, 2006. 100.","DOI":"10.1152\/japplphysiol.01238.2005"},{"key":"277_CR21","doi-asserted-by":"crossref","unstructured":"Athinarayanan SJ, et al., Long-term effects of a novel continuous remote care intervention including nutritional ketosis for the management of type 2 diabetes: a 2-year non-randomized clinical trial. Front Endocrinol, 2019. 10(348).","DOI":"10.3389\/fendo.2019.00348"},{"issue":"5","key":"277_CR22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/MED.0000000000000568","volume":"27","author":"DM Diamond","year":"2020","unstructured":"Diamond DM, O'Neill BJ, Volek JS. Low carbohydrate diet: are concerns with saturated fat, lipids, and cardiovascular disease risk justified? Curr Opin Endocrinol Diabetes Obes. 2020;27(5):291\u2013300.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"3","key":"277_CR23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.metabol.2015.10.028","volume":"65","author":"JS Volek","year":"2016","unstructured":"Volek JS, Freidenreich DJ, Saenz C, Kunces LJ, Creighton BC, Bartley JM, et al. Metabolic characteristics of keto-adapted ultra-endurance runners. Metabolism. 2016;65(3):100\u201310.","journal-title":"Metabolism"},{"issue":"9\u201310","key":"277_CR24","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1093\/milmed\/usz046","volume":"184","author":"RA LaFountain","year":"2019","unstructured":"LaFountain RA, Miller VJ, Barnhart EC, Hyde PN, Crabtree CD, McSwiney FT, et al. Extended ketogenic diet and physical training intervention in military personnel. Mil Med. 2019;184(9\u201310):e538\u201347.","journal-title":"Mil Med"},{"issue":"7","key":"277_CR25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1249\/JSR.0000000000000732","volume":"19","author":"AM Poff","year":"2020","unstructured":"Poff AM, Koutnik AP, Egan B. Nutritional ketosis with ketogenic diets or exogenous ketones: features, convergence, and divergence. Curr Sports Med Rep. 2020;19(7):251\u20139.","journal-title":"Curr Sports Med Rep"},{"issue":"0065\u20137778 (Prin","key":"277_CR26","first-page":"149","volume":"114","author":"G Cahill","year":"2003","unstructured":"Cahill G, Veech RL. Ketoacids? Good medicine? Trans Am Clin Climatol Assoc. 2003;114(0065\u20137778 (Print)):149\u201361 discussion 162-3.","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"277_CR27","doi-asserted-by":"crossref","unstructured":"Gavrilovici C and Rho JM, Metabolic epilepsies amenable to ketogenic therapies: indications, Contra-indications and underlying mechanisms. J Inherit Metab Dis, 2020.","DOI":"10.1002\/jimd.12283"},{"key":"277_CR28","doi-asserted-by":"crossref","unstructured":"Stubbs B, et al., On the metabolism of exogenous ketones in humans. Front Physiol 2017.","DOI":"10.3389\/fphys.2017.00848"},{"key":"277_CR29","doi-asserted-by":"crossref","unstructured":"Vandenberghe, C., et al., Tricaprylin alone increases plasma ketone response more than coconut oil or other medium-chain triglycerides: an acute crossover study in healthy adults. Curr Dev Nutr, 2017. 1(4).","DOI":"10.3945\/cdn.116.000257"},{"issue":"2","key":"277_CR30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3233\/JAD-180202","volume":"64","author":"E Croteau","year":"2018","unstructured":"Croteau E, Castellano CA, Richard MA, Fortier M, Nugent S, Lepage M, et al. Ketogenic medium chain triglycerides increase brain energy metabolism in Alzheimer's disease. J Alzheimers Dis. 2018;64(2):551\u201361.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"277_CR31","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jalz.2018.12.017","volume":"15","author":"M Fortier","year":"2019","unstructured":"Fortier M, Castellano CA, Croteau E, Langlois F, Bocti C, St-Pierre V, et al. A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment. Alzheimers Dement. 2019;15(5):625\u201334.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"277_CR32","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2337\/diab.41.5.641","volume":"41","author":"RH Eckel","year":"1992","unstructured":"Eckel RH, Hanson AS, Chen AY, Berman JN, Yost TJ, Brass EP. Dietary substitution of medium-chain triglycerides improves insulin-mediated glucose metabolism in NIDDM subjects. Diabetes. 1992;41(5):641\u20137.","journal-title":"Diabetes"},{"issue":"7","key":"277_CR33","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3109\/09637481003702114","volume":"61","author":"ME Clegg","year":"2010","unstructured":"Clegg ME. Medium-chain triglycerides are advantageous in promoting weight loss although not beneficial to exercise performance. Int J Food Sci Nutr. 2010;61(7):653\u201379.","journal-title":"Int J Food Sci Nutr"},{"issue":"8","key":"277_CR34","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0271-5317(01)00319-0","volume":"21","author":"V \u00d6\u00f6pik","year":"2001","unstructured":"\u00d6\u00f6pik V, Timpmann S, Medijainen L, Lemberg H. Effects of daily medium-chain triglyceride ingestion on energy metabolism and endurance performance capacity in well-trained runners. Nutr Res. 2001;21(8):1125\u201335.","journal-title":"Nutr Res"},{"issue":"12","key":"277_CR35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226200","volume":"14","author":"DD Thomas","year":"2019","unstructured":"Thomas DD, Stockman MC, Yu L, Meshulam T, McCarthy AC, Ionson A, et al. Effects of medium chain triglycerides supplementation on insulin sensitivity and beta cell function: a feasibility study. PLoS One. 2019;14(12):e0226200.","journal-title":"PLoS One"},{"key":"277_CR36","unstructured":"Misell, L.M., et al., Chronic medium-chain trilgycerol onsumption and endurance performance in trained runners. J Sports Med Phys Fitness, 2001. 41(2)."},{"issue":"6","key":"277_CR37","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1152\/japplphysiol.00393.2006","volume":"101","author":"MS Thorburn","year":"2006","unstructured":"Thorburn MS, et al. Attenuated gastric distress but no benefit to performance with adaptation to octanoate-rich esterified oils in well-trained male cyclists. J Appl Physiol (1985). 2006;101(6):1733\u201343.","journal-title":"J Appl Physiol (1985)"},{"issue":"6116","key":"277_CR38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.1227166","volume":"339","author":"T Shimazu","year":"2013","unstructured":"Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, le Moan N, et al. Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 2013;339(6116):211\u20134.","journal-title":"Science"},{"issue":"2","key":"277_CR39","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.molcel.2016.03.036","volume":"62","author":"Z Xie","year":"2016","unstructured":"Xie Z, Zhang D, Chung D, Tang Z, Huang H, Dai L, et al. Metabolic regulation of gene expression by histone lysine beta-hydroxybutyrylation. Mol Cell. 2016;62(2):194\u2013206.","journal-title":"Mol Cell"},{"issue":"4","key":"277_CR40","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bbrc.2014.04.074","volume":"447","author":"T Wei","year":"2014","unstructured":"Wei T, Tian W, Liu F, Xie G. Protective effects of exogenous \u03b2-hydroxybutyrate on paraquat toxicity in rat kidney. Biochem Biophys Res Commun. 2014;447(4):666\u201371.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"277_CR41","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12699","volume":"17","author":"Y Izuta","year":"2018","unstructured":"Izuta Y, Imada T, Hisamura R, Oonishi E, Nakamura S, Inagaki E, et al. Ketone body 3-hydroxybutyrate mimics calorie restriction via the Nrf2 activator, fumarate, in the retina. Aging Cell. 2018;17(1):e12699.","journal-title":"Aging Cell"},{"key":"277_CR42","doi-asserted-by":"crossref","unstructured":"Meroni E, et al., Metabolic responses in endothelial cells following exposure to ketone bodies. Nutrients, 2018. 10(2).","DOI":"10.3390\/nu10020250"},{"issue":"5","key":"277_CR43","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1471-4159.2007.04483.x","volume":"101","author":"DY Kim","year":"2007","unstructured":"Kim DY, Davis LM, Sullivan PG, Maalouf M, Simeone TA, Brederode J, et al. Ketone bodies are protective against oxidative stress in neocortical neurons. J Neurochem. 2007;101(5):1316\u201326.","journal-title":"J Neurochem"},{"issue":"6116","key":"277_CR44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.1227166","volume":"339","author":"T Shimazu","year":"2013","unstructured":"Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, le Moan N, et al. Suppression of oxidative stress by \u03b2-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 2013;339(6116):211\u20134.","journal-title":"Science"},{"issue":"18","key":"277_CR45","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1089\/neu.2017.5192","volume":"34","author":"G Kong","year":"2017","unstructured":"Kong G, Huang Z, Ji W, Wang X, Liu J, Wu X, et al. The ketone metabolite \u03b2-Hydroxybutyrate attenuates oxidative stress in spinal cord injury by suppression of class I histone deacetylases. J Neurotrauma. 2017;34(18):2645\u201355.","journal-title":"J Neurotrauma"},{"issue":"6","key":"277_CR46","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.molcel.2018.07.036","volume":"71","author":"Y-M Han","year":"2018","unstructured":"Han Y-M, et al. \u03b2-Hydroxybutyrate prevents vascular senescence through hnRNP A1-mediated upregulation of Oct4. Mol Cell. 2018;71(6):1064\u20131078.e5.","journal-title":"Mol Cell"},{"issue":"47","key":"277_CR47","doi-asserted-by":"crossref","first-page":"23813","DOI":"10.1073\/pnas.1912573116","volume":"116","author":"J Miyamoto","year":"2019","unstructured":"Miyamoto J, Ohue-Kitano R, Mukouyama H, Nishida A, Watanabe K, Igarashi M, et al. Ketone body receptor GPR43 regulates lipid metabolism under ketogenic conditions. Proc Natl Acad Sci. 2019;116(47):23813\u201321.","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"277_CR48","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1074\/jbc.M115.676510","volume":"291","author":"X Zou","year":"2016","unstructured":"Zou X, Meng J, Li L, Han W, Li C, Zhong R, et al. Acetoacetate accelerates muscle regeneration and ameliorates muscular dystrophy in mice. J Biol Chem. 2016;291(5):2181\u201395.","journal-title":"J Biol Chem"},{"issue":"1","key":"277_CR49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neuron.2010.09.002","volume":"68","author":"N Juge","year":"2010","unstructured":"Juge N, Gray JA, Omote H, Miyaji T, Inoue T, Hara C, et al. Metabolic control of vesicular glutamate transport and release. Neuron. 2010;68(1):99\u2013112.","journal-title":"Neuron"},{"issue":"3","key":"277_CR50","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"YH Youm","year":"2015","unstructured":"Youm YH, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, et al. The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med. 2015;21(3):263\u20139.","journal-title":"Nat Med"},{"issue":"9","key":"277_CR51","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.celrep.2017.02.004","volume":"18","author":"EL Goldberg","year":"2017","unstructured":"Goldberg EL, Asher JL, Molony RD, Shaw AC, Zeiss CJ, Wang C, et al. Beta-hydroxybutyrate deactivates neutrophil NLRP3 inflammasome to relieve gout flares. Cell Rep. 2017;18(9):2077\u201387.","journal-title":"Cell Rep"},{"key":"277_CR52","unstructured":"Stubbs, B.J., et al., Investigating ketone bodies as immunometabolic countermeasures against respiratory viral infections. Medicine"},{"issue":"8","key":"277_CR53","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477\u201389.","journal-title":"Nat Rev Immunol"},{"key":"277_CR54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.imlet.2017.10.010","volume":"192","author":"Z Sepehri","year":"2017","unstructured":"Sepehri Z, Kiani Z, Afshari M, Kohan F, Dalvand A, Ghavami S. Inflammasomes and type 2 diabetes: an updated systematic review. Immunol Lett. 2017;192:97\u2013103.","journal-title":"Immunol Lett"},{"issue":"1","key":"277_CR55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11745-007-3132-7","volume":"43","author":"CE Forsythe","year":"2008","unstructured":"Forsythe CE, Phinney SD, Fernandez ML, Quann EE, Wood RJ, Bibus DM, et al. Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids. 2008;43(1):65\u201377.","journal-title":"Lipids"},{"issue":"3","key":"277_CR56","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cmet.2018.02.011","volume":"27","author":"L Rajman","year":"2018","unstructured":"Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metab. 2018;27(3):529\u201347.","journal-title":"Cell Metab"},{"issue":"2","key":"277_CR57","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.cell.2013.06.016","volume":"154","author":"L Mouchiroud","year":"2013","unstructured":"Mouchiroud L, Houtkooper RH, Moullan N, Katsyuba E, Ryu D, Cant\u00f3 C, et al. The NAD(+)\/Sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell. 2013;154(2):430\u201341.","journal-title":"Cell"},{"issue":"5","key":"277_CR58","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/iub.1997","volume":"71","author":"RL Veech","year":"2019","unstructured":"Veech RL, Todd King M, Pawlosky R, Kashiwaya Y, Bradshaw PC, Curtis W. The \u201cgreat\u201d controlling nucleotide coenzymes. IUBMB Life. 2019;71(5):565\u201379.","journal-title":"IUBMB Life"},{"issue":"6","key":"277_CR59","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1042\/cs0780579","volume":"78","author":"M Elia","year":"1990","unstructured":"Elia M, Wood S, Khan K, Pullicino E. Ketone body metabolism in lean male adults during short-term starvation, with particular reference to forearm muscle metabolism. Clin Sci (Lond). 1990;78(6):579\u201384.","journal-title":"Clin Sci (Lond)"},{"issue":"3a","key":"277_CR60","doi-asserted-by":"crossref","first-page":"50a","DOI":"10.1016\/S0002-9149(97)00458-X","volume":"80","author":"Y Kashiwaya","year":"1997","unstructured":"Kashiwaya Y, King MT, Veech RL. Substrate signaling by insulin: a ketone bodies ratio mimics insulin action in heart. Am J Cardiol. 1997;80(3a):50a\u201364a.","journal-title":"Am J Cardiol"},{"issue":"2","key":"277_CR61","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/jnc.13958","volume":"141","author":"RJ Pawlosky","year":"2017","unstructured":"Pawlosky RJ, Kemper MF, Kashiwaya Y, King MT, Mattson MP, Veech RL. Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease. J Neurochem. 2017;141(2):195\u2013207.","journal-title":"J Neurochem"},{"issue":"6","key":"277_CR62","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.cell.2020.04.027","volume":"181","author":"QY Ang","year":"2020","unstructured":"Ang QY, et al. Ketogenic diets alter the gut microbiome resulting in decreased intestinal Th17 cells. Cell. 2020;181(6):1263\u20131275.e16.","journal-title":"Cell"},{"key":"277_CR63","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ebiom.2019.08.032","volume":"47","author":"R Nagpal","year":"2019","unstructured":"Nagpal R, Neth BJ, Wang S, Craft S, Yadav H. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment. EBioMedicine. 2019;47:529\u201342.","journal-title":"EBioMedicine"},{"key":"277_CR64","doi-asserted-by":"crossref","first-page":"102950","DOI":"10.1016\/j.ebiom.2020.102950","volume":"59","author":"R Nagpal","year":"2020","unstructured":"Nagpal R, Neth BJ, Wang S, Mishra SP, Craft S, Yadav H. Gut mycobiome and its interaction with diet, gut bacteria and alzheimer's disease markers in subjects with mild cognitive impairment: a pilot study. EBioMedicine. 2020;59:102950.","journal-title":"EBioMedicine"},{"issue":"7","key":"277_CR65","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.cell.2018.04.027","volume":"173","author":"CA Olson","year":"2018","unstructured":"Olson CA, et al. The gut microbiota mediates the anti-seizure effects of the ketogenic diet. Cell. 2018;173(7):1728\u20131741.e13.","journal-title":"Cell"},{"issue":"2","key":"277_CR66","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cmet.2018.10.015","volume":"29","author":"P Puchalska","year":"2019","unstructured":"Puchalska P, et al. Hepatocyte-macrophage acetoacetate shuttle protects against tissue fibrosis. Cell Metab. 2019;29(2):383\u2013398.e7.","journal-title":"Cell Metab"},{"key":"277_CR67","doi-asserted-by":"crossref","unstructured":"Uchihashi, M., et al., Cardiac-specific Bdh1 overexpression ameliorates oxidative stress and cardiac remodeling in pressure overload-induced heart failure. Circ Heart Fail, 2017. 10(12).","DOI":"10.1161\/CIRCHEARTFAILURE.117.004417"},{"issue":"7","key":"277_CR68","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s42255-019-0087-y","volume":"1","author":"M Garc\u00eda-Caballero","year":"2019","unstructured":"Garc\u00eda-Caballero M, Zecchin A, Souffreau J, Truong ACK, Teuwen LA, Vermaelen W, et al. Role and therapeutic potential of dietary ketone bodies in lymph vessel growth. Nat Metab. 2019;1(7):666\u201375.","journal-title":"Nat Metab"},{"issue":"5","key":"277_CR69","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.cell.2019.07.048","volume":"178","author":"CW Cheng","year":"2019","unstructured":"Cheng CW, et al. Ketone body signaling mediates intestinal stem cell homeostasis and adaptation to diet. Cell. 2019;178(5):1115\u20131131.e15.","journal-title":"Cell"},{"issue":"4","key":"277_CR70","doi-asserted-by":"crossref","first-page":"e124079","DOI":"10.1172\/jci.insight.124079","volume":"4","author":"JL Horton","year":"2019","unstructured":"Horton JL, Davidson MT, Kurishima C, Vega RB, Powers JC, Matsuura TR, et al. The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense. JCI insight. 2019;4(4):e124079.","journal-title":"JCI insight"},{"issue":"6","key":"277_CR71","doi-asserted-by":"crossref","first-page":"e006573","DOI":"10.1161\/CIRCHEARTFAILURE.119.006573","volume":"13","author":"J Byrne Nikole","year":"2020","unstructured":"Byrne Nikole J, et al. Chronically elevating circulating ketones can reduce cardiac inflammation and blunt the development of heart failure. Circ Heart Fail. 2020;13(6):e006573.","journal-title":"Circ Heart Fail"},{"issue":"12","key":"277_CR72","doi-asserted-by":"crossref","first-page":"e004417","DOI":"10.1161\/CIRCHEARTFAILURE.117.004417","volume":"10","author":"M Uchihashi","year":"2017","unstructured":"Uchihashi M, et al. Cardiac-specific Bdh1 overexpression ameliorates oxidative stress and cardiac remodeling in pressure overload\u2013induced heart failure. Circ Heart Fail. 2017;10(12):e004417.","journal-title":"Circ Heart Fail"},{"issue":"22","key":"277_CR73","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1161\/CIRCULATIONAHA.119.045033","volume":"141","author":"S Selvaraj","year":"2020","unstructured":"Selvaraj S, Kelly DP, Margulies KB. Implications of altered ketone metabolism and therapeutic ketosis in heart failure. Circulation. 2020;141(22):1800\u201312.","journal-title":"Circulation"},{"issue":"18","key":"277_CR74","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1161\/CIRCULATIONAHA.118.036459","volume":"139","author":"R Nielsen","year":"2019","unstructured":"Nielsen R, M\u00f8ller N, Gormsen LC, Tolbod LP, Hansson NH, Sorensen J, et al. Cardiovascular effects of treatment with the ketone body 3-hydroxybutyrate in chronic heart failure patients. Circulation. 2019;139(18):2129\u201341.","journal-title":"Circulation"},{"key":"277_CR75","doi-asserted-by":"crossref","unstructured":"Gormsen LC, et al., Ketone body infusion with 3-hydroxybutyrate reduces myocardial glucose uptake and increases blood flow in humans: a positron emission tomography study. J Am Heart Assoc, 2017. 6(3).","DOI":"10.1161\/JAHA.116.005066"},{"key":"277_CR76","doi-asserted-by":"crossref","unstructured":"Song JP, et al., Elevated plasma \u03b2-hydroxybutyrate predicts adverse outcomes and disease progression in patients with arrhythmogenic cardiomyopathy. Sci Transl Med, 2020. 12(530).","DOI":"10.1126\/scitranslmed.aay8329"},{"issue":"1","key":"277_CR77","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0006-8993(91)90755-K","volume":"561","author":"A Yoshino","year":"1991","unstructured":"Yoshino A, Hovda DA, Kawamata T, Katayama Y, Becker DP. Dynamic changes in local cerebral glucose utilization following cerebral concussion in rats: evidence of a hyper- and subsequent hypometabolic state. Brain Res. 1991;561(1):106\u201319.","journal-title":"Brain Res"},{"issue":"3","key":"277_CR78","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cmet.2017.08.005","volume":"26","author":"MN Roberts","year":"2017","unstructured":"Roberts MN, et al. A ketogenic diet extends longevity and healthspan in adult mice. Cell Metab. 2017;26(3):539\u2013546.e5.","journal-title":"Cell Metab"},{"issue":"3","key":"277_CR79","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.cmet.2017.08.004","volume":"26","author":"JC Newman","year":"2017","unstructured":"Newman JC, et al. Ketogenic diet reduces midlife mortality and improves memory in aging mice. Cell Metab. 2017;26(3):547\u2013557.e8.","journal-title":"Cell Metab"},{"issue":"5\u20136","key":"277_CR80","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1159\/000499563","volume":"40","author":"TR Wood","year":"2018","unstructured":"Wood TR, Stubbs BJ, Juul SE. Exogenous ketone bodies as promising neuroprotective agents for developmental brain injury. Dev Neurosci. 2018;40(5\u20136):451\u201362.","journal-title":"Dev Neurosci"},{"issue":"11","key":"277_CR81","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1194\/jlr.R048975","volume":"55","author":"LB Gano","year":"2014","unstructured":"Gano LB, Patel M, Rho JM. Ketogenic diets, mitochondria, and neurological diseases. J Lipid Res. 2014;55(11):2211\u201328.","journal-title":"J Lipid Res"},{"key":"277_CR82","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3389\/fneur.2019.00585","volume":"10","author":"H Yang","year":"2019","unstructured":"Yang H, Shan W, Zhu F, Wu J, Wang Q. Ketone bodies in neurological diseases: focus on neuroprotection and underlying mechanisms. Front Neurol. 2019;10:585.","journal-title":"Front Neurol"},{"issue":"12","key":"277_CR83","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1194\/jlr.R046706","volume":"55","author":"ML Prins","year":"2014","unstructured":"Prins ML, Matsumoto JH. The collective therapeutic potential of cerebral ketone metabolism in traumatic brain injury. J Lipid Res. 2014;55(12):2450\u20137.","journal-title":"J Lipid Res"},{"key":"277_CR84","doi-asserted-by":"crossref","first-page":"105727","DOI":"10.1016\/j.clineuro.2020.105727","volume":"192","author":"N Arora","year":"2020","unstructured":"Arora N, Mehta TR. Role of the ketogenic diet in acute neurological diseases. Clin Neurol Neurosurg. 2020;192:105727.","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"277_CR85","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1080\/02699052.2018.1429025","volume":"32","author":"A McDougall","year":"2018","unstructured":"McDougall A, Bayley M, Munce SE. The ketogenic diet as a treatment for traumatic brain injury: a scoping review. Brain Inj. 2018;32(4):416\u201322.","journal-title":"Brain Inj"},{"issue":"1","key":"277_CR86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.jcbfm.9600543","volume":"28","author":"ML Prins","year":"2008","unstructured":"Prins ML. Cerebral metabolic adaptation and ketone metabolism after brain injury. J Cereb Blood Flow Metab : official journal of the International Society of Cerebral Blood Flow and Metabolism. 2008;28(1):1\u201316.","journal-title":"J Cereb Blood Flow Metab : official journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"277_CR87","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neurobiolaging.2019.09.015","volume":"86","author":"BJ Neth","year":"2020","unstructured":"Neth BJ, Mintz A, Whitlow C, Jung Y, Solingapuram Sai K, Register TC, et al. Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer's disease: a pilot study. Neurobiol Aging. 2020;86:54\u201363.","journal-title":"Neurobiol Aging"},{"key":"277_CR88","doi-asserted-by":"crossref","unstructured":"Grammatikopoulou MG, et al., To keto or not to keto? A systematic review of randomized controlled trials assessing the effects of ketogenic therapy on Alzheimer disease. Adv Nutr, 2020.","DOI":"10.1093\/advances\/nmaa073"},{"issue":"3","key":"277_CR89","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1172\/JCI106017","volume":"48","author":"P Felig","year":"1969","unstructured":"Felig P, Owen OE, Wahren J, Cahill GF Jr. Amino acid metabolism during prolonged starvation. J Clin Invest. 1969;48(3):584\u201394.","journal-title":"J Clin Invest"},{"issue":"4","key":"277_CR90","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tem.2019.01.006","volume":"30","author":"AP Koutnik","year":"2019","unstructured":"Koutnik AP, D'Agostino DP, Egan B. Anticatabolic effects of ketone bodies in skeletal muscle. Trends Endocrinol Metab. 2019;30(4):227\u20139.","journal-title":"Trends Endocrinol Metab"},{"key":"277_CR91","doi-asserted-by":"crossref","unstructured":"Koutnik AP, et al., Ketone bodies attenuate wasting in models of atrophy. J Cachexia Sarcopenia Muscle 2020","DOI":"10.1002\/jcsm.12554"},{"key":"277_CR92","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2049-3002-2-18","volume":"2","author":"SK Shukla","year":"2014","unstructured":"Shukla SK, Gebregiworgis T, Purohit V, Chaika NV, Gunda V, Radhakrishnan P, et al. Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia. Cancer Metab. 2014;2:18.","journal-title":"Cancer Metab"},{"issue":"1","key":"277_CR93","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ajcn\/47.1.42","volume":"47","author":"KC Fearon","year":"1988","unstructured":"Fearon KC, Borland W, Preston T, Tisdale MJ, Shenkin A, Calman KC. Cancer cachexia: influence of systemic ketosis on substrate levels and nitrogen metabolism. Am J Clin Nutr. 1988;47(1):42\u20138.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"277_CR94","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1172\/JCI113570","volume":"82","author":"KS Nair","year":"1988","unstructured":"Nair KS, Welle SL, Halliday D, Campbell RG. Effect of beta-hydroxybutyrate on whole-body leucine kinetics and fractional mixed skeletal muscle protein synthesis in humans. J Clin Invest. 1988;82(1):198\u2013205.","journal-title":"J Clin Invest"},{"key":"277_CR95","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fphys.2017.00310","volume":"8","author":"T Vandoorne","year":"2017","unstructured":"Vandoorne T, de Smet S, Ramaekers M, van Thienen R, de Bock K, Clarke K, et al. Intake of a ketone ester drink during recovery from exercise promotes mTORC1 signaling but not glycogen resynthesis in human muscle. Front Physiol. 2017;8:310.","journal-title":"Front Physiol"},{"issue":"16","key":"277_CR96","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1001\/jama.2011.1556","volume":"306","author":"KE Covinsky","year":"2011","unstructured":"Covinsky KE, Pierluissi E, Johnston CB. Hospitalization-associated disability: \u201cshe was probably able to ambulate, but I\u2019m not sure.\u201d. Jama. 2011;306(16):1782\u201393.","journal-title":"Jama"},{"key":"277_CR97","doi-asserted-by":"crossref","unstructured":"Church, D.D., et al., Mitigation of muscle loss in stressed physiology: military relevance. Nutrients, 2019. 11(8).","DOI":"10.3390\/nu11081703"},{"issue":"7","key":"277_CR98","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1682\/JRRD.2014.07.0165","volume":"52","author":"BT Corona","year":"2015","unstructured":"Corona BT, Rivera JC, Owens JG, Wenke JC, Rathbone CR. Volumetric muscle loss leads to permanent disability following extremity trauma. J Rehabil Res Dev. 2015;52(7):785\u201392.","journal-title":"J Rehabil Res Dev"},{"issue":"10","key":"277_CR99","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1172\/JCI105650","volume":"46","author":"OE Owen","year":"1967","unstructured":"Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF Jr. Brain metabolism during fasting. J Clin Invest. 1967;46(10):1589\u201395.","journal-title":"J Clin Invest"},{"issue":"3","key":"277_CR100","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1172\/JCI106016","volume":"48","author":"OE Owen","year":"1969","unstructured":"Owen OE, Felig P, Morgan AP, Wahren J, Cahill GF Jr. Liver and kidney metabolism during prolonged starvation. J Clin Invest. 1969;48(3):574\u201383.","journal-title":"J Clin Invest"},{"issue":"6","key":"277_CR101","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1172\/JCI108057","volume":"55","author":"RS Sherwin","year":"1975","unstructured":"Sherwin RS, Hendler RG, Felig P. Effect of ketone infusions on amino acid and nitrogen metabolism in man. J Clin Invest. 1975;55(6):1382\u201390.","journal-title":"J Clin Invest"},{"issue":"1","key":"277_CR102","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/bj2260043","volume":"226","author":"A Maiz","year":"1985","unstructured":"Maiz A, Moldawer LL, Bistrian BR, Birkhahn RH, Long CL, Blackburn GL. Monoacetoacetin and protein metabolism during parenteral nutrition in burned rats. Biochem J. 1985;226(1):43\u201350.","journal-title":"Biochem J"},{"issue":"8","key":"277_CR103","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0026-0495(83)90106-3","volume":"32","author":"S Phinney","year":"1983","unstructured":"Phinney S, et al. The human metabolic response to chronic ketosis without caloric restriction: preservation of submaximal exercise capability with reduced carbohydrate oxidation. Metabolism. 1983;32(8):769\u201376.","journal-title":"Metabolism"},{"issue":"4","key":"277_CR104","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/ajcn\/nqy170","volume":"108","author":"HH Thomsen","year":"2018","unstructured":"Thomsen HH, Rittig N, Johannsen M, M\u00f8ller AB, J\u00f8rgensen JO, Jessen N, et al. Effects of 3-hydroxybutyrate and free fatty acids on muscle protein kinetics and signaling during LPS-induced inflammation in humans: anticatabolic impact of ketone bodies. Am J Clin Nutr. 2018;108(4):857\u201367.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"277_CR105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/bjc.1987.149","volume":"56","author":"MJ Tisdale","year":"1987","unstructured":"Tisdale MJ, Brennan RA, Fearon KC. Reduction of weight loss and tumour size in a cachexia model by a high fat diet. Br J Cancer. 1987;56(1):39\u201343.","journal-title":"Br J Cancer"},{"key":"277_CR106","doi-asserted-by":"crossref","unstructured":"Nakamura, K., et al., A Ketogenic formula prevents tumor progression and cancer cachexia by attenuating systemic inflammation in colon 26 tumor-bearing mice. Nutrients, 2018. 10(2).","DOI":"10.3390\/nu10020206"},{"key":"277_CR107","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cmet.2020.06.020","volume":"32","author":"I Tomita","year":"2020","unstructured":"Tomita I, Kume S, Sugahara S, Osawa N, Yamahara K, Yasuda-Yamahara M, et al. SGLT2 inhibition mediates protection from diabetic kidney disease by promoting ketone body-induced mTORC1 inhibition. Cell Metab. 2020;32:404\u2013419.e6.","journal-title":"Cell Metab"},{"issue":"7327","key":"277_CR108","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/nature09584","volume":"468","author":"S Sengupta","year":"2010","unstructured":"Sengupta S, Peterson TR, Laplante M, Oh S, Sabatini DM. mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature. 2010;468(7327):1100\u20134.","journal-title":"Nature"},{"issue":"3","key":"277_CR109","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/dmr.5610050304","volume":"5","author":"EO Balasse","year":"1989","unstructured":"Balasse EO, Fery F. Ketone-body production and disposal\u2014effects of fasting, diabetes, and exercise. Diabetes Metab Rev. 1989;5(3):247\u201370.","journal-title":"Diabetes Metab Rev"},{"issue":"4","key":"277_CR110","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2337\/diab.34.4.326","volume":"34","author":"F Fery","year":"1985","unstructured":"Fery F, Balasse EO. Ketone-body production and disposal in diabetic ketosis\u2014a comparison with fasting ketosis. Diabetes. 1985;34(4):326\u201332.","journal-title":"Diabetes"},{"issue":"4","key":"277_CR111","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/07315724.2020.1752846","volume":"39","author":"ML Kackley","year":"2020","unstructured":"Kackley ML, Short JA, Hyde PN, LaFountain RA, Buga A, Miller VJ, et al. A pre-workout supplement of ketone salts, caffeine, and amino acids improves high-intensity exercise performance in keto-na\u00efve and keto-adapted individuals. J Am Coll Nutr. 2020;39(4):290\u2013300.","journal-title":"J Am Coll Nutr"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-020-00277-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-020-00277-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-020-00277-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T18:49:01Z","timestamp":1669056541000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-020-00277-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,2]]},"references-count":111,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["277"],"URL":"https:\/\/doi.org\/10.1007\/s11357-020-00277-y","relation":{},"ISSN":["2509-2715","2509-2723"],"issn-type":[{"value":"2509-2715","type":"print"},{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,2]]},"assertion":[{"value":"5 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"J.C.N. is a co-founder of and shareholder in BHB Therapeutics LTD., which is developing products relating to ketone bodies, and is on the scientific advisory board of Virta Health, Inc. B.J.S. is a shareholder of HVMN Inc., which markets products relating to ketone bodies and of BHB Therapeutics Ltd. J.C.N., B.J.S, and A.P.K are inventors on patents related to the use of ketone bodies. J.S.V. receives royalties for low-carbohydrate nutrition books; is founder, consultant, and stockholder of Virta Health, Inc. and is a member of the advisory boards for Atkins Nutritionals Inc., UCAN Co., and Ketone Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}